It has been demonstrated that SIRT6 inhibits Smad3 activation, a member of the Smad family involved in TGF-β signaling, through H3K9 deacetylation, thereby suppressing the expression of key genes related to liver fibrosis and contributing to fibrosis regression [64]. This evidence concerns the gene SIRT6 and Hepatic fibrosis.